ANTI-AP2 ANTIBODIES AND ANTIGEN BINDING AGENTS TO TREAT METABOLIC DISORDERS
This invention is in the area of improved anti-aP2 antibodies and antigen binding agents, and compositions thereof, which target the lipid chaperone aP2/FABP4 (referred to as "aP2") for use in treating disorders such as diabetes, obesity, cardiovascular disease, fatty liver disease, and/or...
Saved in:
Main Authors | , , , , , , , , , , |
---|---|
Format | Patent |
Language | English French German |
Published |
07.03.2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!